GLYCOMINDS Diagnostics (2014) LTD.

Glycominds Diagnostics is a clinical laboratory diagnostics company specializing in non-invasive biomarker-based solutions for gastrointestinal diseases. The company develops and offers blood-based diagnostic tests for detection, prognosis, and monitoring of inflammatory bowel diseases (IBD), including Crohn's disease and Celiac disease. Product portfolio includes biomarkers for IBD diagnosis, Crohn's disease prognosis assessment, and monitoring of mucosal healing and anti-TNF therapy response. Glycominds positions its offerings as cost-effective alternatives to invasive diagnostic techniques such as endoscopy, providing gastroenterologists and primary care providers with accurate, non-invasive options for patient stratification and treatment monitoring. The company serves healthcare providers managing patients with gastrointestinal inflammatory conditions across multiple care settings.